This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe

Savings Deadline Expires In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2-4 December 2024
Convention Centre DublinDublin, Ireland

Ruiz Astigarraga
Head of Manufacturing - Cell Therapy at Galapagos
Speaker

Profile

Ruiz is responsible for the Galapagos decentralized cell therapy manufacturing operations in the EU region. At Galapagos, Ruiz has been part from the early development to clinical implementation of an innovative CAR-T decentralized/point-of-care manufacturing model with 1-week vein-to-vein time. Ruiz has previously worked at Kite, from construction to licensure of Kite's CAR-T commercial manufacturing facility in the Netherlands. Earlier in his career at Novartis, Ruiz worked in commercial manufacturing of vaccines and biologics, tech transfers, process validation and start-up of GMP manufacturing facilities. Ruiz holds a Masters degree in Microbiology.

Agenda Sessions

  • How can Decentralized Manufacturing be Implemented at Patient Point-of-care?

    12:00
  • Galapagos' Innovative Decentralized Manufacturing Model for Cell Therapy

    15:30